Regen BioPharma implements gene silencing technology in killing cancer stem cells – News-Medical.net
|
Regen BioPharma implements gene silencing technology in killing cancer stem cells
News-Medical.net Regen BioPharma Inc. (OTCBB: RGBP) and (PINK: RGBP) reported today the successful implementation of its gene silencing technology, covered by patent # 8,263,571, in killing cancer stem cells. The technology involves using RNA interference to block … Regen BioPharma, Inc. BORIS Gene Silencing Technology Successfully Utilized by … |
